Debates & Insight

Debates & Insight
How pharma Tweetchats can drive healthcare innovation
Sponsored

How pharma Tweetchats can drive healthcare innovation

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect w

Debates & Insight
Doctor networks: The rules of engagement for pharma
Sponsored

Doctor networks: The rules of engagement for pharma

As online doctor networks have grown they have also developed their own rules around how members interact, what sort of information they are looking for and how they like to engage, meaning pha

Debates & Insight
The Healthcare Meetings Forum 2013
Sponsored

The Healthcare Meetings Forum 2013

Healthcare meetings are experiencing a time of change, as new compliance regulations, the rise of digital and the flexing needs of healthcare providers force adaptation.

Debates & Insight
How to effectively engage in the rare disease space
Sponsored

How to effectively engage in the rare disease space

Engaging with the relevant healthcare stakeholders for pharma company sales forces increasingly requires on-going adapatation and new skills, but engaging in the rare disease space is even hard